Clinical Trial Update: Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating the addition of radiation therapy to standard immunotherapy with or without chemotherapy for PD-L1–negative advanced non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Adenosquamous Carcinoma
• Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer
• Stage Iiic Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Adenocarcinoma, Lung Adenosquamous Carcinoma | Phase 2, Phase 3 | Status: SUSPENDED